Umbilical Cord‐Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial

Knee osteoarthritis (OA) is a leading cause of pain and disability. Although conventional treatments show modest benefits, pilot and phase I/II trials with bone marrow (BM) and adipose‐derived (AD) mesenchymal stromal cells (MSCs) point to the feasibility, safety, and occurrence of clinical and stru...

Descripción completa

Detalles Bibliográficos
Autores principales: Matas, Jose, Orrego, Mario, Amenabar, Diego, Infante, Catalina, Tapia‐Limonchi, Rafael, Cadiz, Maria Ignacia, Alcayaga‐Miranda, Francisca, González, Paz L., Muse, Emilio, Khoury, Maroun, Figueroa, Fernando E., Espinoza, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392367/
https://www.ncbi.nlm.nih.gov/pubmed/30592390
http://dx.doi.org/10.1002/sctm.18-0053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392367/
https://www.ncbi.nlm.nih.gov/pubmed/30592390
http://dx.doi.org/10.1002/sctm.18-0053

Ejemplares similares